Your session is about to expire
← Back to Search
Standard of Care for Atrial Fibrillation (CATCH-AF Trial)
CATCH-AF Trial Summary
This trial is investigating whether the Kardia Mobile monitoring device is a superior strategy for diagnosing Atrial Fibrillation (AF) in comparison to normal ambulatory monitoring with a 24-hour Holter monitor.
CATCH-AF Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowCATCH-AF Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.CATCH-AF Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many participants are engaging in this medical experiment?
"Affirmative. Data hosted on clinicaltrials.gov indicates that this research, which was first made available to the public on December 18th 2018, is currently recruiting participants. All told, 220 individuals are needed to be sourced from 1 medical centre."
Are there any openings available for participants in this trial?
"Indeed, details available on clinicaltrials.gov show that this trial is still accepting participants, having been initially posted in December 2018 and updated most recently at the end of August 2022. A total of 220 enrollees are required for the single medical center involved in this study."
Share this study with friends
Copy Link
Messenger